Даваа–Баасан 08:30–20:00 · Бямба 09:00–16:00
Now showing 1 - 10 of 10
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Evaluating the impact of morphological parameters and developmental speed on blastocyst ploidy and sex: A retrospective study
    (The Korean Society for Reproductive Medicine, 2026-02)
    Baatarsuren, Mungunshagai
    ;
    ;
    Baljinnyam, Lkhagvasuren
    ;
    Ganbaatar, Chinzorig
    ;
    Sengebaljir, Davaakhuu
    OBJECTIVE: In assisted reproductive technology (ART), transferring a single euploid blastocyst optimizes pregnancy outcomes and reduces the risk of multiple gestation. Chromosomal aneuploidy, relatively prevalent among patients of advanced maternal age, remains a leading cause of ART failure. This study investigated the relationships among blastocyst morphology, developmental speed, ploidy status, and sex. METHODS: This retrospective cohort study analyzed 856 blastocysts from 439 patients who underwent minimal stimulation in vitro fertilization (IVF) cycles at the Ojinmed IVF Center, Mongolia, between May 2019 and June 2024. Embryo grading followed the Gardner and Schoolcraft system, assessing blastocyst expansion, inner cell mass grade, trophectoderm (TE) grade, and developmental timing. TE biopsies were evaluated for euploidy, whole or segmental aneuploidy, and mosaicism. RESULTS: Euploidy, aneuploidy, and mosaicism rates were 49.8%, 33.4%, and 16.8%, respectively, exhibiting significant correlations with maternal age. Women at least 35 years old faced increased aneuploidy risk (adjusted odds ratio [aOR], 3.34; 95% confidence interval [CI], 2.35 to 4.61; p<0.001) and reduced euploidy rates (aOR, 0.29; 95% CI, 0.21 to 0.41; p<0.001). Among morphological parameters, only TE grade significantly predicted ploidy, with TE grade C linked to elevated aneuploidy risk (aOR, 3.06; 95% CI, 1.42 to 6.10; p<0.01). Faster blastocyst expansion was correlated with male sex (aOR, 0.95; 95% CI, 0.91 to 0.99; p=0.03). Segmental and whole-chromosomal abnormalities were exclusively age-related. CONCLUSION: Maternal age and TE grade are strong predictors of blastocyst ploidy, and expansion speed is associated with sex. These findings support improved embryo selection strategies to promote successful IVF.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    The Impact of Ambient Air Pollution on Outcomes of Single Vitrified-Warmed Blastocyst Transfer
    (Elsevier BV, 2026)
    Baatarsuren, Mungunshagai
    ;
    ;
    Ganbaatar, Chinzorig
    ;
    Sengebaljir, Davaakhuu
    ;
    Enkhbaatar, Sandag
  • Some of the metrics are blocked by your 
    Item type:Publication,
    SERPINA1 генийн S, Z мутант аллелийг бодит хугацааны ПГУ-аар илрүүлсэн нь
    Үндэслэл: SERPINA1 генийн мутацийг судлах, эмнэлзүйд S, Z мутант аллелийг илрүүлэхэд найдвартай, хугацаа богино шаарддаг молекул биологийн шинжилгээний аргачлал шаардлагатай байна. Өмнөх судалгаануудад SERPINA1 генийн S, Z мутант аллелийг судлахдаа уламжлалт полимеразын гинжин урвал (ПГУ)-д суурилсан огтлогдсон хэрчмийн уртын полиморфизм (ОХУП), аллель өвөрмөц ПГУ зэрэг нь аргуудыг түлхүү ашиглажээ. Бид SERPINA1 генийн S, Z мутант аллелийг илрүүлэх TaqMan проб бүхий бодит хугацааны ПГУ (бхПГУ)-ын аргыг загварчилсан ба уг аргыг харьцуулан судлах шаардлагад үндэслэн энэ судалгааг хийлээ. Зорилго: SERPINA1 генийн мутацийг тодорхойлох ОХУП ба бхПГУ-ын аргуудыг харьцуулан судалж, аналитик мэдрэг, өвөрмөц чанарыг тогтоох. Арга, аргачлал: Судалгаанд 473 хүний ДНХ сорьц ашигласан. SERPINA1 генийн М, S, Z аллелиудыг ОХУП ба бхПГУ-аар илрүүлсэн. S, Z мутант аллель илэрсэн тохиолдлуудад нуклеотидын дараалал тогтоох Сангерын арга ашиглан дарааллыг тогтоож баталгаажуулсан. Статистик боловсруулалтанд MedCalc програм ашигласан каппа коэффициент, аналитик мэдрэг ба өвөрмөц чанаруудыг тооцоолов. Үр дүн: Үр дүнгээр SERPINA1 генийн МZ генотип 0.21% (n=1), MS генотип 1.06% (n=5), SS генотип 0.42% (n=2)тай илэрсэн. ОХУП аргын аналитик мэдрэг чанар 71.43% (95% ИИ, 29.04-96.33%), харин бхПГУ-ын аргын аналитик мэдрэг чанар 100.0% (95% ИИ, 99.21-100.0%) байсан. Дүгнэлт: ОХУП аргатай харьцуулахад бхПГУ нь аналитик мэдрэг чанараар илүү байгаа нь тогтоогдлоо.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Traditional Mongolian medicine RuXian-1 suppress the breast hyperplasia by GRP78/PERK/CHOP pathway in rat model
    (2024-08-30)
    Shuangquan Zhao
    ;
    Chimedragchaa Chimedtseren
    ;
    ;
    In this study we aimed to study the protective effect of RuXian-1, which is a traditional Mongolian medicine on hyperplasia of mammary glands in rats and to explore its possible mechanism. Methods: The rat model of breast hyperplasia was induced by intramuscular injection of estradiol benzoate. The rats were randomly divided into 4 groups: saline treatment group (negative control), estrogen treatment group (model group), RuXian-1 treatment group and raloxifene treatment group (positive control). RuXian-1 group and raloxifene group were given 3.0 g/kg of RuXian-1 and 1.8 mg/kg of raloxifene daily for 4 weeks, respectively. After treatment, the breast tissue of each group was harvested and confirmed the expressions levels of glucose-related protein 78 (GRP78), C/EBP homologous protein (CHOP), and protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) which were known that functions as an endoplasmic reticulum stress marker by Western blotting. Results: Compared with the normal group, the GRP78, PERK and CHOP protein levels in the breast tissue of the model group were significantly decreased. Compared with the model group, the expression of GRP78, PERK and CHOP in RuXian-1 group significantly increased, the expression of GRP78 and CHOP of raloxifene significantly increased (p < 0.05), and the expression of PERK did not change. Conclusion: The Mongolian medicine RuXian-1 has therapeutic effect on mammary hyperplasia in rats, and its therapeutic mechanism is related to activating the GRP78/PERK/CHOP signaling pathway and promoting mammary gland cell apoptosis.
    Scopus© Citations 1
  • Some of the metrics are blocked by your 
    Item type:Publication,
    The hyperplasia of the mammary gland effect of the Mongolian Remedy RuXian-I in rats reduced by estrogen and progesterone via inhibition of MAPK and NF-κB pathways
    (2024-04-28)
    Shuangquan Zhao
    ;
    Chimedragchaa Chimedtseren
    ;
    ; ;
    Bin Zhang
    Background: The aim of the present study was to evaluate whether the HMG (Hyperplasia of the Mammary Gland) effect of RuXian-I in estrogen- and progestogen- induced HMG rats is mediated through the activation of MAPK (Mitogen activated protein kinase) and NF-κB signaling pathways. Materials and methods: Fifty virgin female Wistar rats were randomly divided into in control and HMG, RuXian-I (0.75 g·kg−1, 1.5 g·kg−1, 3 g·kg−1, respectively) groups, 10 in each. Injections of estrogen and progestogen were given to establish rat models of HMG and RuXian-I at the same time. Changes in nipple heights were measured; pathologic changes of HMG in rats were also observed under a light microscope; the phosphorylation levels of MAPK and NF κB and the expression levels of TNF-α and IL-1β were measured. Results: Compared with the control group, the nipple diameters and height were increased significantly, the numbers of MG lobules were increased, there were changes in breast histopathology, the levels of TNF-α and IL-1β increased significantly, and MAPK and NF-κB were activated in HMG rats. Compared with the HMG model group, the increased nipple height was decreased, the numbers of MG lobules were reduced, the degree of HMG in rats was alleviated obviously, and the phosphorylation level of MAPK and NF-κB and cytokines TNF- α and IL-1β levels in serum were decreased by RuXian-I treatment. Conclusion: Those results suggest RuXian-I has protective and therapeutic effects on HMG rats induced by estrogen and progestogen and is likely to activate MAPK and NF-κB signaling pathways.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Histopathological, molecular, and phylogenetic analyses of Echinococcus species isolated from humans in Mongolia, 2010-2024
    Echinococcosis in humans caused by hydatid cyst of Echinococcus spp., remains a significant public health concern in Mongolia. In this study, we aimed to characterize the epidemiology, histopathological features, and molecular diversity of Echinococcus isolates from human infections. A retrospective analysis of surgically confirmed cases diagnosed between 2010 and 2024 was conducted. A histopathological examination of resected or biopsied cyst material was employed to assess cyst morphology and associated tissue responses. Molecular identification was performed using PCR amplification and sequencing of the mitochondrial cytochrome c oxidase subunit 1 (COX1) gene, followed by Bayesian phylogenetic analysis. A total of 311 human echinococcosis cases from multiple provinces were analyzed. Furthermore, COX1 sequences identified 181 isolates of Echinococcus granulosus sensu stricto (G1), 106 of E. canadensis (G6/7), 19 of E. canadensis (G10), and 5 of E. multilocularis, revealing 11 haplotypes. Geographic clustering of selected genotypes was observed. Bayesian phylogenetic reconstruction demonstrated clustering of Mongolian isolates within established Echinococcus lineages. Time-scaled analyses provided insights into the relative temporal relationships among lineages; however, divergence time estimates were interpreted cautiously owing to reliance on a substitution rate prior and single mitochondrial marker. These findings provide updated epidemiological and molecular data on human echinococcosis in Mongolia. However, given the single-locus design and exclusive use of human-derived samples, interpretations regarding transmission dynamics remain inferential and require confirmation through integrated host-based studies.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    SNP-SNP positive interaction between MMP2 and MMP12 increases the risk of COPD
    Determining SNP-SNP interaction of the disease has become important for further investigation of pathogenesis and experimental research. Although many studies have been published on the effect of MMPs gene polymorphisms on chronic obstructive pulmonary disease (COPD), there is a lack of information on SNP-SNP and SNP-environment interactions. This study aimed to investigate the interaction between the polymorphisms of MMP1, MMP2, MMP9 and MMP12 genes and its combined effect with smoking on the risk of developing COPD. Totally 181 COPD patients and 292 healthy individuals were involved. Blood samples from the participants were tested for genotyping and data were collected through questionnaires. Genotyping was performed with nested allele-specific polymerase chain reaction (AS-PCR) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). SNP-SNP and SNP-environment interactions were investigated using multifactor dimensionality reduction and logistic regression analysis. The result showed that participants with high nicotine dependence and heavy smokers had a higher risk of COPD than non-smokers. Also, G/G genotype (cOR = 5.83; 95% CI, 1.19-28.4, p = 0.029) of MMP2 rs243864 and T/T genotype (cOR = 1.79; 95% CI, 1.16-2.76, p = 0.008) of MMP12 rs652438 independently contributes to the susceptibility of COPD. For SNP-SNP interaction, the positive interaction between rs243864 G/G genotype of MMP2 and rs652438 T/T genotype of MMP12 was found, and the combination of risk genotypes has a high risk of COPD (OR = 12.92; 95% CI, 1.46-114.4, p = 0.021). Moreover, the combination of T/T genotype of MMP12 rs652438 and smoking-related factors increases the risk of COPD approximately 4.5 to 6-fold. The results suggests that there is a combination of MMP2, MMP12, and smoking-related factors may increase the risk of developing COPD.
    Scopus© Citations 3
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Clinical and neonatal outcomes of complete zona pellucida removal by laser-assisted hatching after single vitrified-warmed blastocyst transfer
    (Springer Science and Business Media LLC, 2024-01)
    Baatarsuren, Mungunshagai
    ;
    ;
    Ganbaatar, Chinzorig
    ;
    Sengebaljir, Davaakhuu
    ;
    Erdenekhuyag, Belguune
    Laser-assisted hatching (LAH) is a widely used and unavoidable technique in assisted reproductive technology after frozen embryo transfer (FET). We aimed to investigate the safety and efficacy of completely ZP (zona pellucida) removed by an assisted laser group compared to an intact group after FET. This retrospective study involved 320 SVBT  single vitrified-warmed blastocyst transfers of 213 patients who underwent clomiphene citrate (CC) based minimal stimulation protocol. This study compared 160 SVBT with ZP that were completely removed using laser-assisted (laser beams of 10-15, a wavelength of 1.48 μm, and duration of 1.8-2.2 ms) to 160 cases of intact SVBT. Fisher's exact test, chi-squared test, and logistic regression are used for statistical analysis. The women's age, cause of infertility, BMI, transferred embryo day, insemination methods, and blastocyst grade were not significantly different between two groups. The implantation rate (66.2% vs. 51.2%, P < 0.01), the clinical pregnancy rate (CPR, 52.5% vs. 39.3%, P = 0.01), and the live birth rate (LBR, 43.7% vs. 29.3%, P < 0.01) were significantly higher in the completely ZP removed than the intact group. In logistic regression analysis, the laser-assisted hatching group showed about 2 times higher implantation rate and CPR and LBR than the control group. But miscarriage, gestational weeks, gender, birth weight, and twin births were insignificant between two groups. Our study suggests ZP free embryo transfer by assisted laser is more effective and safer than intact embryo transfer.
    Scopus© Citations 4
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Noneffectiveness of cryostorage duration on clinical and neonatal outcomes after single vitrified-warmed blastocyst transfers
    (Springer Science+Business Media, 2024-07-11)
    Mungunshagai Baatarsuren
    ;
    ;
    Chinzorig Ganbaatar
    ;
    Davaakhuu Sengebaljir
    ;
    Belguune Erdenekhuyag
    Abstract Background In the current era of assisted reproductive technology, the strategy of single vitrified-warmed blastocyst transfer (SVBT) is acknowledged for positively impacting clinical outcomes and preventing the risk of multiple conceptions. Previous studies have indicated that blastocyst grade and the day of blastocyst positively correlate with outcomes. Moreover, storage duration has no significant effect on survival rates, clinical outcomes, and neonatal outcomes. However, some researchers express controversial opinions on cryostorage duration, and their findings suggest a negative impact on clinical outcomes. These results remain subject to controversy, and limited studies exist regarding the outcomes after SVBT. Therefore, our study aims to investigate the impact of the day of blastocyst, blastocyst grade, and blastocyst cryostorage duration on clinical and neonatal outcomes following SVBT in patients who underwent clomiphene-citrate-based minimal stimulation. Material and methods In this study, retrospective cohort study data collected from June 2015 to April 2023 included 2107 patients with first SVBT cycles who underwent a clomiphene-based minimal ovarian stimulation protocol or a drug-free natural protocol at the Ojinmed IVF Center. Patients were categorized into four groups based on blastocyst cryostorage duration: group 1 (< 2 months, n = 882), group 2 (3–6 months, n = 794), group 3 (7–12 months, n = 187), group 4 (13–24 months, n = 126), and group 5 (25–81 months, n = 118). The patient’s clinical and neonatal outcomes were compared with cryostorage duration after the propensity score matched. Result Multivariable logistic regression analysis revealed that prolonged cryostorage duration insignificantly correlated with clinical outcomes. Additionally, neonatal outcomes are not correlated with cryostorage duration. Conclusions The patient must consider several parameters when selecting embryos for transfer, including the duration of cryostorage. Our study results show that for the first single vitrified-warmed blastocyst transfer of patients who underwent clomiphene citrate-based minimal stimulation, cryostorage duration does not affect outcomes.